Kyverna Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Emeryville, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Kyverna Therapeutics, Inc. has filed 185 SEC EDGAR filings since 05 Oct 2023

SEC filing history

Showing 26-40 of 40 matching filings.

Per page
25
Current page
2
8-K File 001-41947

CURRENT REPORT

Filing date
13 Jan 2025
Reporting date
13 Jan 2025
Next action
Verify source filing
8-K File 001-41947

CURRENT REPORT

Filing date
21 Oct 2024
Reporting date
20 Oct 2024
Next action
Verify source filing
8-K File 001-41947

CURRENT REPORT

Filing date
16 Sep 2024
Reporting date
13 Sep 2024
Next action
Verify source filing
8-K File 001-41947

8-K

Filing date
26 Mar 2024
Reporting date
26 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41947

8-K

Filing date
12 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .